Thomas Pangerl
Impact in
- Neurology top 10%
- Neuroblastoma Research and Treatments
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances
Papers in
- Epidemiology 11
- Neuroendocrine Tumor Research Advances 11
-
- Monoclonal and Polyclonal Antibodies Research 5
- Radiopharmaceutical Chemistry and Applications 5
- Co-authors
- Irene Virgolini (12 shared papers)M. Leimer (7 shared papers)P. Angelberger (5 shared papers)Markus Peck‐Radosavljevic (4 shared papers)Claudia Bischof (4 shared papers)Robert Dudczak (5 shared papers)Gerhard Hamilton (4 shared papers)Amir Kurtaran (6 shared papers)
In The Last Decade
Thomas Pangerl
14 papers receiving 432 citations
Peers
Comparison fields: 5 of 43
- Neurology 141
- Epidemiology 284
- Oncology 220
- Radiology, Nuclear Medicine and Imaging 162
- Endocrinology, Diabetes and Metabolism 52
Countries citing papers authored by Thomas Pangerl
This map shows the geographic impact of Thomas Pangerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pangerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pangerl more than expected).
Fields of papers citing papers by Thomas Pangerl
This network shows the impact of papers produced by Thomas Pangerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pangerl. The network helps show where Thomas Pangerl may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Pangerl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829. | 1998 | 95 |
| 2 | 2002 | 74 | |
| 3 | 1999 | 69 | |
| 4 | New trends in peptide receptor radioligands. | 2001 | 37 |
| 5 | 111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung. | 2001 | 32 |
| 6 | 1997 | 29 | |
| 7 | Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells. | 2001 | 28 |
| 8 | New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy. | 2000 | 18 |
| 9 | 2008 | 17 | |
| 10 | 2010 | 16 | |
| 11 | 1999 | 14 | |
| 12 | 1998 | 10 | |
| 13 | 1998 | 4 | |
| 14 | 1998 | 3 |
About Thomas Pangerl
Thomas Pangerl is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology and Surgery, having authored 14 papers that have together received 446 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (11 papers), Lung Cancer Research Studies (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Glycosylation and Glycoproteins Research (2 papers), Neuroblastoma Research and Treatments (2 papers), Lymphoma Diagnosis and Treatment (1 paper) and Abdominal Trauma and Injuries (1 paper). The work is most often cited by research in Neurology (141 citations), Epidemiology (284 citations), Oncology (220 citations), Radiology, Nuclear Medicine and Imaging (162 citations) and Endocrinology, Diabetes and Metabolism (52 citations). Thomas Pangerl has collaborated with scholars based in Austria, Italy and France. Frequent co-authors include Irene Virgolini, M. Leimer, P. Angelberger, Markus Peck‐Radosavljevic, Claudia Bischof, Robert Dudczak, Gerhard Hamilton, Amir Kurtaran, Klaus Kaserer and Peter Smith‐Jones. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Molecular Cancer Therapeutics, Endocrinology, BMC Systems Biology and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.